About Oxford Endovascular
Oxford Endovascular is a company based in Oxford (United Kingdom) founded in 2015. Oxford Endovascular has raised $22.72 million across 8 funding rounds from investors including University of Oxford, EIT Health and European Union. The company has 7 employees as of October 31, 2021. Oxford Endovascular offers products and services including OxiFlow. Oxford Endovascular operates in a competitive market with competitors including Rapid Medical, CoAxia, Cerus Endovascular, Anaconda Biomed and Fluid Biomed, among others.
- Headquarter Oxford, United Kingdom
- Employees 7 as on 31 Oct, 2021
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Oxford Endovascular Limited
- Date of Incorporation 09 Sep, 2015
- Jurisdiction OXFORD, UNITED KINGDOM
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$22.72 M (USD)
in 8 rounds
-
Latest Funding Round
$10.16 M (USD), Series A
May 20, 2024
-
Investors
University of Oxford
& 9 more
-
Employee Count
7
as on Oct 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Oxford Endovascular
Oxford Endovascular offers a comprehensive portfolio of products and services, including OxiFlow.
Diverts blood flow to prevent aneurysm rupture safely.
Funding Insights of Oxford Endovascular
Oxford Endovascular has successfully raised a total of $22.72M across 8 strategic funding rounds. The most recent funding activity was a Series A round of $10.16 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Oxford Endovascular
Oxford Endovascular has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include University of Oxford, EIT Health and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Early-stage tech and offline investments are managed across sectors.
|
Locked | Locked | Locked | |
|
Investment management services for science ventures are provided in Oxford.
|
Locked | Locked | Locked |
Investor details for Oxford Endovascular
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Oxford Endovascular
Investment portfolio details for Oxford Endovascular
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Oxford Endovascular
Detailed financials for Oxford Endovascular
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Oxford Endovascular Comparisons
Peer comparison for Oxford Endovascular
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Oxford Endovascular
Oxford Endovascular operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rapid Medical, CoAxia, Cerus Endovascular, Anaconda Biomed and Fluid Biomed, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Neurovascular interventional devices including distal access catheters are developed.
|
|
| Locked | Locked | Locked |
Catheter-based treatment for cerebral ischemia
|
|
| Locked | Locked | Locked |
Interventional neuroradiology devices are developed for minimally invasive aneurysm treatment.
|
|
| Locked | Locked | Locked |
Medical devices for mechanical thromboectomy and clot removal are developed.
|
|
| Locked | Locked | Locked |
A hybrid polymer-metal stent for brain aneurysms is developed.
|
Detailed competitors of Oxford Endovascular
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Oxford Endovascular
Complete news archive for Oxford Endovascular
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Oxford Endovascular
Oxford Endovascular was founded in 2015.
Oxford Endovascular is headquartered in Oxford, United Kingdom. It is registered at Oxford, Oxfordshire, United Kingdom.
Oxford Endovascular is a funded company, having raised a total of $22.72M across 8 funding rounds to date.
As of Oct 31, 2021, the latest employee count at Oxford Endovascular is 7.
Oxford Endovascular was established in 2015 as a spin-out from the University of Oxford in the United Kingdom. Focus is placed on the medical device sector, specifically neurovascular treatments. Operations involve the creation of laser-cut metal alloy tubes that are delivered via catheter into brain blood vessels. These devices expand to form meshes that redirect blood flow, supporting aneurysm healing. Development occurs in Oxford, targeting patients with neurovascular conditions.
Oxford Endovascular's top competitors include Rapid Medical, Fluid Biomed and Anaconda Biomed.
Oxford Endovascular offers OxiFlow.
Oxford Endovascular has 10 investors. Key investors include University of Oxford, EIT Health, European Union, EIC Fund, and Vulpes.